Exportação concluída — 

Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis

Detalhes bibliográficos
Ano de defesa: 2013
Autor(a) principal: Gonzaga, Daniel Tadeu Gomes lattes
Orientador(a): Silva, Fernando de Carvalho da lattes
Banca de defesa: Freitas, Rossimiriam Pereira de lattes, Faria, Robson Xavier lattes, Silva, Barbara Vasconcellos da lattes, Jordâo, Alessandro Kappel lattes, Martins, Daniela de Luna lattes
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Programa de Pós-graduação em Química
Departamento: Química
País: Não Informado pela instituição
Palavras-chave em Português:
HIV
Palavras-chave em Inglês:
HIV
Área do conhecimento CNPq:
Link de acesso: https://app.uff.br/riuff/handle/1/20721
Resumo: In this study the main objective was to synthesize a series of functionalized 1,2,3-triazoles in regioposições 1H and 2H and evaluate these triazoles against various biological targets: Mtb-glucosidase enzymes, HIV, Candida albicans, and lock P2X7 receptor. 101a-e-phenyl ester 101 type alcohols 1H-1,2,3-triazoles were synthesized by Huisgen cycloaddition between azides and aromatic alkyne catalyzed by Cu (I) (CuAAC). From the triazole alcohols 101a and some transformations such as esterification to generate compounds 184a-t, alkylation was performed to obtain ethers 185a-oe partial oxidation to produce aldehydes 102a-e. In the quest to find new analogs 1H-1,2,3-triazoles were prepared 186a and the oximes, hydrazones and acyl hydrazones 187a-187i1 by addition of hydroxylamine appropriately substituted phenyl hydrazines and aldehydes to isoniazid respectively obtained and 4-vinyl previously 1H-1,2,3-triazole (188) through a Wittig reaction. Likewise, the 5-amino-1-phenyl-1H-1,2,3-triazol-4-methyl carboxylate (189) was obtained using the method of enolate addition of aromatic azides. Regarding the number of 2H-1,2,3-triazole This was prepared by a sequence of reactions involving the synthesis of 41a and osazonas from the nucleophilic addition to D-glucose by phenyl substituted hydrazines. Then the osazonas suffered oxidative cyclization leading to osotriazóis 42a and which finally underwent oxidative cleavage of a reaction leading to the formation of aldehydes 2H-1,2,3-triazole 43ae. The 3-carboxaldehyde-2H-1,2,3-triazole derivatives 43a and were the key synthetic intermediates for obtaining of all other substances from the class of 2H-1,2,3-triazole. However, only the aldehyde 43a originating from the reaction with phenylhydrazine, was employed for the other derivatives, those containing substituents on the portion of phenylhydrazine (42b-e) presented insoluble in the solvents used. Thus, were synthesized oxime 191, hydrazones and acyl hydrazones 192a-h and alcohol 2H-1,2,3-triazole 193 through the reduction reaction of 43a and from this, the 2H-1,2,3-triazole esters 194a of the 2H-1,2,3-triazole ethers 195a-c were prepared. The compounds were evaluated in biological tests for tuberculosis by the Dra. Maria Cristina Lourenço (FioCruz / IOC), inhibition of glucosidase by Dr. Floriano Paes Silva Junior group (FioCruz / IOC), HIV virus by Dr.Thiago Moreno de Souza (FioCruz / IOC) and his research group of Prof. antifungal pelogrupo Emerson da Silva Lima (UFAM), by Prof. anticancer. Patricia Zancan (UFRJ) and the antagonism of the P2X7 receptor by Dr. Robson Xavier Faria (FioCruz / IOC) group. For testing against Mycobacterium tuberculosis, the etiological agent of tuberculosis, no sample showed active. IC50 values ​​between 25 and 100 / ml. Importantly, the WHO recommends that compounds having values ​​below 6.25 g / mL are considered active. The evaluation was performed glycosidase inhibition front of maltase and α-amylase enzymes. In the inhibition of maltase was obtained with the highest four substances having enzyme inhibition percent inhibition ranging from 60.3 to 99.4% and IC50 ranging from 53.9 to 92.8 uM. The reference drug is Acarbose which showed 48.1% inhibition and IC50 uM 108.8. Three compounds were promising inhibition against α-amylase having high degree of enzyme inhibition ranging from 60.1 to 88.6% (acarbose showed 99.6% inhibition). Biological test against HIV resulted in eleven substances AltoTripAdvisor inhibition of viral growth. Percent inhibition of HIV ranged from 80.8 to 98%. The evaluation against Candida albicans resulted in no active compound, not leading to no reduction in growth. In relation to the blockade of P2X7 receptor, four substances were greatly active possessing IC50 in nM range and are being considered for other experiments.
id UFF-2_40a6853e7c8dfd2d406d286605279afb
oai_identifier_str oai:app.uff.br:1/20721
network_acronym_str UFF-2
network_name_str Repositório Institucional da Universidade Federal Fluminense (RIUFF)
repository_id_str
spelling 2021-03-10T20:51:01Z2014-11-032021-03-10T20:51:01Z2013-07-30https://app.uff.br/riuff/handle/1/20721In this study the main objective was to synthesize a series of functionalized 1,2,3-triazoles in regioposições 1H and 2H and evaluate these triazoles against various biological targets: Mtb-glucosidase enzymes, HIV, Candida albicans, and lock P2X7 receptor. 101a-e-phenyl ester 101 type alcohols 1H-1,2,3-triazoles were synthesized by Huisgen cycloaddition between azides and aromatic alkyne catalyzed by Cu (I) (CuAAC). From the triazole alcohols 101a and some transformations such as esterification to generate compounds 184a-t, alkylation was performed to obtain ethers 185a-oe partial oxidation to produce aldehydes 102a-e. In the quest to find new analogs 1H-1,2,3-triazoles were prepared 186a and the oximes, hydrazones and acyl hydrazones 187a-187i1 by addition of hydroxylamine appropriately substituted phenyl hydrazines and aldehydes to isoniazid respectively obtained and 4-vinyl previously 1H-1,2,3-triazole (188) through a Wittig reaction. Likewise, the 5-amino-1-phenyl-1H-1,2,3-triazol-4-methyl carboxylate (189) was obtained using the method of enolate addition of aromatic azides. Regarding the number of 2H-1,2,3-triazole This was prepared by a sequence of reactions involving the synthesis of 41a and osazonas from the nucleophilic addition to D-glucose by phenyl substituted hydrazines. Then the osazonas suffered oxidative cyclization leading to osotriazóis 42a and which finally underwent oxidative cleavage of a reaction leading to the formation of aldehydes 2H-1,2,3-triazole 43ae. The 3-carboxaldehyde-2H-1,2,3-triazole derivatives 43a and were the key synthetic intermediates for obtaining of all other substances from the class of 2H-1,2,3-triazole. However, only the aldehyde 43a originating from the reaction with phenylhydrazine, was employed for the other derivatives, those containing substituents on the portion of phenylhydrazine (42b-e) presented insoluble in the solvents used. Thus, were synthesized oxime 191, hydrazones and acyl hydrazones 192a-h and alcohol 2H-1,2,3-triazole 193 through the reduction reaction of 43a and from this, the 2H-1,2,3-triazole esters 194a of the 2H-1,2,3-triazole ethers 195a-c were prepared. The compounds were evaluated in biological tests for tuberculosis by the Dra. Maria Cristina Lourenço (FioCruz / IOC), inhibition of glucosidase by Dr. Floriano Paes Silva Junior group (FioCruz / IOC), HIV virus by Dr.Thiago Moreno de Souza (FioCruz / IOC) and his research group of Prof. antifungal pelogrupo Emerson da Silva Lima (UFAM), by Prof. anticancer. Patricia Zancan (UFRJ) and the antagonism of the P2X7 receptor by Dr. Robson Xavier Faria (FioCruz / IOC) group. For testing against Mycobacterium tuberculosis, the etiological agent of tuberculosis, no sample showed active. IC50 values ​​between 25 and 100 / ml. Importantly, the WHO recommends that compounds having values ​​below 6.25 g / mL are considered active. The evaluation was performed glycosidase inhibition front of maltase and α-amylase enzymes. In the inhibition of maltase was obtained with the highest four substances having enzyme inhibition percent inhibition ranging from 60.3 to 99.4% and IC50 ranging from 53.9 to 92.8 uM. The reference drug is Acarbose which showed 48.1% inhibition and IC50 uM 108.8. Three compounds were promising inhibition against α-amylase having high degree of enzyme inhibition ranging from 60.1 to 88.6% (acarbose showed 99.6% inhibition). Biological test against HIV resulted in eleven substances AltoTripAdvisor inhibition of viral growth. Percent inhibition of HIV ranged from 80.8 to 98%. The evaluation against Candida albicans resulted in no active compound, not leading to no reduction in growth. In relation to the blockade of P2X7 receptor, four substances were greatly active possessing IC50 in nM range and are being considered for other experiments.No presente trabalho o objetivo principal foi o de sintetizar uma série de 1,2,3- triazóis funcionalizados nas regioposições 1H e 2H e avaliar esses triazóis contra vários alvos biológicos: Mycobacterium tuberculosis, enzimas glicosidases, o vírus HIV, Candida albicans e, bloqueio do receptor P2X7. Foram sintetizados álcoois 101a-e e éster 101-f do tipo 1H 1,2,3-triazóis por meio de cicloadição de Huisgen entre alcinos e azidas aromáticas catalisada por Cu(I) (CuAAC). A partir dos álcoois triazólicos 101a-e foram realizadas algumas transformações como esterificação para gerar os compostos 184a-t, alquilação para obter os éteres 185a-o e oxidação parcial para produzir os aldeídos 102a-e. Na busca para encontrar novos análogos de 1H-1,2,3-triazóis foram preparadas as oximas 186a-e , hidrazonas e acil-hidrazonas 187a-187i1 por intermédio de adição de hidroxilamina, fenil-hidrazinas devidamente substituídas e isoniazida respectivamente aos aldeídos obtidos anteriormente e 4-vinil 1H-1,2,3-triazol (188) por intermédio de uma reação de Wittig. Da mesma forma o 5 amino-1-fenil-1H-1,2,3-triazol-4-carboxilato de metila (189) foi obtido usando a metodologia de adição do enolato em azidas aromáticas. Em relação à série de 2H-1,2,3-triazóis, esta foi preparada através de uma sequência de reações envolvendo a síntese de osazonas 41a e a partir da adição nucleofílica na D-glicose por fenil-hidrazinas substituídas. Em seguida, as osazonas sofreram ciclização oxidativa levando aos osotriazóis 42a-e que por fim, sofreram uma reação de clivagem oxidativa levando à formação dos aldeídos 2H-1,2,3-triazólicos 43ae. Os derivados 3-carboxaldeído-2H-1,2,3-triazóis 43a-e foram os intermediários sintéticos chave para obtenção de todas as outras substâncias da classe dos 2H-1,2,3- triazóis. No entanto, apenas o aldeído 43a oriundo da reação com a fenil-hidrazina, foi empregado, pois os demais derivados, aqueles que continham substituintes na porção da fenil-hidrazina (42b-e), se apresentaram insolúveis nos solventes utilizados. Assim, foram sintetizados a oxima 191, as hidrazonas e acil hidrazonas 192a-h e o álcool 2H- 1,2,3-triazólico 193 através da reação de redução de 43a e a partir deste, os ésteres 2H- 1,2,3-triazólicos 194a-d e os éteres 2H-1,2,3-triazólicos 195a c foram preparados. Os compostos foram avaliadas em testes biológicos contra a tuberculose pelo grupo da Dra. Maria Cristina Lourenço (FioCruz/IOC), inibição de glicosidase pelo grupo do Dr. Floriano Paes Silva Junior(FioCruz/IOC),contra o vírus HIV pelo Dr.Thiago Moreno de Souza (FioCruz/IOC) e seu grupo de pesquisa,antifúngico pelogrupo do Prof. Emerson da Silva Lima (UFAM), anticancerígeno pela Profa. Patrícia Zancan (UFRJ) e o antagonismo do receptor P2X7 pelo grupo do Dr. Robson Xavier Faria (FioCruz/IOC). Para o teste frente ao Mycobacterium tuberculosis, agente etiológico da tuberculose, nenhuma amostra se mostrou ativa. Os valores de IC50 variaram de 25 a 100 μg/mL. É importante notar que a OMS preconiza que os compostos que tenham valores abaixo de 6,25 μg/mL são considerados ativos. A avaliação da inibição de glicosidase foi realizada frente às enzimas maltase e α-amilase. Na inibição da maltase obtiveram-se quatro substâncias que apresentaram maior inibição enzimática tendo percentagem de inibição variando de 60,3 a 99,4 % e IC50 variando de 53,9 a 92,8 μM. O fármaco de referência é a Acarbose que apresentou 48,1 % de inibição e 108,8 μM de IC50. Três compostos se mostraram promissores frente a inibição da α-amilase apresentando alto grau de inibição enzimática variando de 60,1 a 88,6 % (acarbose mostrou 99,6 % de inibição). O teste biológico frente ao vírus HIV resultou em onze substâncias com altoíndice de inibição de crescimento viral. A percentagem de inibição do vírus HIV variou de 80,8 a 98 %. A avaliação frente ao fungo Candida albicans não resultou em nenhum composto ativo, não levando a nenhuma redução do crescimento. Em relação ao bloqueio do receptor P2X7, quatro substâncias se apresentaram bastante ativas possuindo IC50 na escala de nM e estão sendo consideradas para outros experimentos.application/pdfporCC-BY-SAinfo:eu-repo/semantics/openAccessSíntese orgânicaTriazolComposição farmacológicaHIVOrganic synthesistriazolePharmaceutical compositionHIVCNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICASíntese e avaliação biológica de 1H e 2H-1,2,3-triazóisSynthesis and biological evaluation of 1 H and 2H-1,2,3-triazoleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisSilva, Fernando de Carvalho dahttp://lattes.cnpq.br/7183643963574044Ferreira, Vítor Franciscohttp://genos.cnpq.br:12010/dwlattes/owa/prc_imp_cv_int?f_cod=K4783135Y6Freitas, Rossimiriam Pereira deCV: http://lattes.cnpq.br/0117954518807172Faria, Robson Xavierhttp://lattes.cnpq.br/6124019896265890Silva, Barbara Vasconcellos dahttp://lattes.cnpq.br/3874886795138290Jordâo, Alessandro Kappelhttp://lattes.cnpq.br/2003461080025290Martins, Daniela de Lunahttp://lattes.cnpq.br/7211566541475026http://lattes.cnpq.br/5956368188565441Gonzaga, Daniel Tadeu GomesPrograma de Pós-graduação em QuímicaQuímicareponame:Repositório Institucional da Universidade Federal Fluminense (RIUFF)instname:Universidade Federal Fluminense (UFF)instacron:UFF1/207212026-04-07 13:57:26.428oai:app.uff.br:1/20721Repositório InstitucionalPUBhttps://app.uff.br/oai/requestriuff@id.uff.bropendoar:21202026-04-07T16:57:26Repositório Institucional da Universidade Federal Fluminense (RIUFF) - Universidade Federal Fluminense (UFF)false
dc.title.por.fl_str_mv Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
dc.title.alternative.eng.fl_str_mv Synthesis and biological evaluation of 1 H and 2H-1,2,3-triazole
title Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
spellingShingle Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
Gonzaga, Daniel Tadeu Gomes
Síntese orgânica
Triazol
Composição farmacológica
HIV
Organic synthesis
triazole
Pharmaceutical composition
HIV
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
title_short Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
title_full Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
title_fullStr Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
title_full_unstemmed Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
title_sort Síntese e avaliação biológica de 1H e 2H-1,2,3-triazóis
author Gonzaga, Daniel Tadeu Gomes
author_facet Gonzaga, Daniel Tadeu Gomes
author_role author
dc.contributor.advisor1.fl_str_mv Silva, Fernando de Carvalho da
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/7183643963574044
dc.contributor.advisor-co1.fl_str_mv Ferreira, Vítor Francisco
dc.contributor.advisor-co1Lattes.fl_str_mv http://genos.cnpq.br:12010/dwlattes/owa/prc_imp_cv_int?f_cod=K4783135Y6
dc.contributor.referee1.fl_str_mv Freitas, Rossimiriam Pereira de
dc.contributor.referee1Lattes.fl_str_mv CV: http://lattes.cnpq.br/0117954518807172
dc.contributor.referee2.fl_str_mv Faria, Robson Xavier
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/6124019896265890
dc.contributor.referee3.fl_str_mv Silva, Barbara Vasconcellos da
dc.contributor.referee3Lattes.fl_str_mv http://lattes.cnpq.br/3874886795138290
dc.contributor.referee4.fl_str_mv Jordâo, Alessandro Kappel
dc.contributor.referee4Lattes.fl_str_mv http://lattes.cnpq.br/2003461080025290
dc.contributor.referee5.fl_str_mv Martins, Daniela de Luna
dc.contributor.referee5Lattes.fl_str_mv http://lattes.cnpq.br/7211566541475026
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/5956368188565441
dc.contributor.author.fl_str_mv Gonzaga, Daniel Tadeu Gomes
contributor_str_mv Silva, Fernando de Carvalho da
Ferreira, Vítor Francisco
Freitas, Rossimiriam Pereira de
Faria, Robson Xavier
Silva, Barbara Vasconcellos da
Jordâo, Alessandro Kappel
Martins, Daniela de Luna
dc.subject.por.fl_str_mv Síntese orgânica
Triazol
Composição farmacológica
HIV
topic Síntese orgânica
Triazol
Composição farmacológica
HIV
Organic synthesis
triazole
Pharmaceutical composition
HIV
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
dc.subject.eng.fl_str_mv Organic synthesis
triazole
Pharmaceutical composition
HIV
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
description In this study the main objective was to synthesize a series of functionalized 1,2,3-triazoles in regioposições 1H and 2H and evaluate these triazoles against various biological targets: Mtb-glucosidase enzymes, HIV, Candida albicans, and lock P2X7 receptor. 101a-e-phenyl ester 101 type alcohols 1H-1,2,3-triazoles were synthesized by Huisgen cycloaddition between azides and aromatic alkyne catalyzed by Cu (I) (CuAAC). From the triazole alcohols 101a and some transformations such as esterification to generate compounds 184a-t, alkylation was performed to obtain ethers 185a-oe partial oxidation to produce aldehydes 102a-e. In the quest to find new analogs 1H-1,2,3-triazoles were prepared 186a and the oximes, hydrazones and acyl hydrazones 187a-187i1 by addition of hydroxylamine appropriately substituted phenyl hydrazines and aldehydes to isoniazid respectively obtained and 4-vinyl previously 1H-1,2,3-triazole (188) through a Wittig reaction. Likewise, the 5-amino-1-phenyl-1H-1,2,3-triazol-4-methyl carboxylate (189) was obtained using the method of enolate addition of aromatic azides. Regarding the number of 2H-1,2,3-triazole This was prepared by a sequence of reactions involving the synthesis of 41a and osazonas from the nucleophilic addition to D-glucose by phenyl substituted hydrazines. Then the osazonas suffered oxidative cyclization leading to osotriazóis 42a and which finally underwent oxidative cleavage of a reaction leading to the formation of aldehydes 2H-1,2,3-triazole 43ae. The 3-carboxaldehyde-2H-1,2,3-triazole derivatives 43a and were the key synthetic intermediates for obtaining of all other substances from the class of 2H-1,2,3-triazole. However, only the aldehyde 43a originating from the reaction with phenylhydrazine, was employed for the other derivatives, those containing substituents on the portion of phenylhydrazine (42b-e) presented insoluble in the solvents used. Thus, were synthesized oxime 191, hydrazones and acyl hydrazones 192a-h and alcohol 2H-1,2,3-triazole 193 through the reduction reaction of 43a and from this, the 2H-1,2,3-triazole esters 194a of the 2H-1,2,3-triazole ethers 195a-c were prepared. The compounds were evaluated in biological tests for tuberculosis by the Dra. Maria Cristina Lourenço (FioCruz / IOC), inhibition of glucosidase by Dr. Floriano Paes Silva Junior group (FioCruz / IOC), HIV virus by Dr.Thiago Moreno de Souza (FioCruz / IOC) and his research group of Prof. antifungal pelogrupo Emerson da Silva Lima (UFAM), by Prof. anticancer. Patricia Zancan (UFRJ) and the antagonism of the P2X7 receptor by Dr. Robson Xavier Faria (FioCruz / IOC) group. For testing against Mycobacterium tuberculosis, the etiological agent of tuberculosis, no sample showed active. IC50 values ​​between 25 and 100 / ml. Importantly, the WHO recommends that compounds having values ​​below 6.25 g / mL are considered active. The evaluation was performed glycosidase inhibition front of maltase and α-amylase enzymes. In the inhibition of maltase was obtained with the highest four substances having enzyme inhibition percent inhibition ranging from 60.3 to 99.4% and IC50 ranging from 53.9 to 92.8 uM. The reference drug is Acarbose which showed 48.1% inhibition and IC50 uM 108.8. Three compounds were promising inhibition against α-amylase having high degree of enzyme inhibition ranging from 60.1 to 88.6% (acarbose showed 99.6% inhibition). Biological test against HIV resulted in eleven substances AltoTripAdvisor inhibition of viral growth. Percent inhibition of HIV ranged from 80.8 to 98%. The evaluation against Candida albicans resulted in no active compound, not leading to no reduction in growth. In relation to the blockade of P2X7 receptor, four substances were greatly active possessing IC50 in nM range and are being considered for other experiments.
publishDate 2013
dc.date.issued.fl_str_mv 2013-07-30
dc.date.available.fl_str_mv 2014-11-03
2021-03-10T20:51:01Z
dc.date.accessioned.fl_str_mv 2021-03-10T20:51:01Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://app.uff.br/riuff/handle/1/20721
url https://app.uff.br/riuff/handle/1/20721
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv CC-BY-SA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv CC-BY-SA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Química
dc.publisher.department.fl_str_mv Química
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal Fluminense (RIUFF)
instname:Universidade Federal Fluminense (UFF)
instacron:UFF
instname_str Universidade Federal Fluminense (UFF)
instacron_str UFF
institution UFF
reponame_str Repositório Institucional da Universidade Federal Fluminense (RIUFF)
collection Repositório Institucional da Universidade Federal Fluminense (RIUFF)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal Fluminense (RIUFF) - Universidade Federal Fluminense (UFF)
repository.mail.fl_str_mv riuff@id.uff.br
_version_ 1881031943062028288